[1]张洪艳,刘风静,孟胜喜,等.清化活血方对高尿酸血症患者血清炎症因子及肠道菌群的影响临床研究[J].陕西中医,2025,46(10):1330-1335.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.006]
 ZHANG Hongyan,LIU Fengjing,MENG Shengxi,et al.Effect of Qinghua Huoxue formula on serum inflammatory factors and intestinal microbiota in patients with hyperuricemia[J].,2025,46(10):1330-1335.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.006]
点击复制

清化活血方对高尿酸血症患者血清炎症因子及肠道菌群的影响临床研究

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年10期
页码:
1330-1335
栏目:
临床研究
出版日期:
2025-10-05

文章信息/Info

Title:
Effect of Qinghua Huoxue formula on serum inflammatory factors and intestinal microbiota in patients with hyperuricemia
作者:
张洪艳1刘风静1孟胜喜1王宇新1马丽3彭文波1王兵1李翠娟2孙永宁3
(1.上海交通大学医学院附属第六人民医院,上海 200233;2.陕西中医药大学,陕西 咸阳 712046;3.上海市中医医院,上海 200040)
Author(s):
ZHANG Hongyan1LIU Fengjing1MENG Shengxi1WANG Yuxin1MA Li3PENG Wenbo1WANG Bing1LI Cuijuan2SUN Yongning3
(1.Affiliated Sixth People’s Hospital of Shanghai Jiaotong University Medical College,Shanghai 200233,China;2.Shaanxi University of Traditional Chinese Medicine,Xianyang 712046,China;3.Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai 200040,China)
关键词:
高尿酸血症清化活血方湿热内蕴证肠道菌群炎症因子白细胞介素-6
Keywords:
HyperuricemiaQinghua Huoxue formulaInternal damp-heat syndromeIntestinal floraInflammatory factorInterleukin-6
分类号:
R 589.7
DOI:
DOI:10.3969/j.issn.1000-7369.2025.10.006
文献标志码:
A
摘要:
目的:探讨清化活血方对湿热内蕴型高尿酸血症(HUA)患者血清炎症因子及肠道菌群的影响。方法:纳入符合中医湿热内蕴证型的HUA患者52例,按随机数字表法分为治疗组和对照组各26例,治疗组患者予清化活血方颗粒剂,对照组予等量安慰剂共治疗12周。服药期间每周对患者进行1次随访,对所有患者进行饮食及运动指导。比较治疗前后两组临床疗效及血清白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)、γ-干扰素(IFN-γ)、白介素-1β(IL-1β)等炎症因子水平,留取患者粪便样本测定两组患者肠道菌群多样性及丰度变化。结果:治疗12周后,治疗组患者较对照组舒张压下降(P<0.05);治疗组患者总胆固醇(TC)及低密度脂蛋白胆固醇(LDL-C)水平下降,与对照组比较差异有统计学意义(P<0.05),与治疗前相比差异有统计学意义(均P<0.01);治疗12周后,治疗组与对照组患者尿酸水平差异有统计学意义(P<0.05);治疗前后两组患者肝肾功能差异无统计学意义(P>0.05);治疗后两组患者血清炎症因子IFN-γ及IL-1β比较差异有统计学意义(均P<0.05);治疗组患者治疗前后菌群多样性差异无统计学意义(P>0.05);对于菌群丰度分析发现门水平治疗组患者治疗前后拟杆菌门、放线菌门、酸杆菌门、绿弯菌门、硝化菌门、甲基杆菌门、GAL15菌门丰度与治疗前均存在差异;对照组患者仅芽单孢菌门和绿弯菌门丰度存在差异;属水平的分析发现治疗组患者治疗前后拟杆菌属、布劳特菌属、双歧杆菌属、肠杆菌属、鞘氨醇单胞菌属、gaiella(放线菌门下的菌属之一)丰度存在差异,对照组治疗前后仅布劳特菌属、鞘氨醇单胞菌丰度差异有统计学意义(均P<0.05)。结论:清化活血方能够降低湿热内蕴型HUA患者尿酸水平,同时调节患者血脂,改善舒张压,与体内促炎因子IFN-γ和IL-1β表达降低,肠道布劳特菌属、双歧杆菌属等优势菌群丰度增加,拟杆菌丰度降低有关。
Abstract:
Objective:To observe the effect of Qinghua Huoxue(QHHX) formula on serum inflammatory factors and gut microbiota in hyperuricemia (HUA) patients with damp heat intrinsic syndrome.Methods:52 patients with HUA were divided into two groups randomly,26 patients in treatment group and 26 in control group.After enrollment,patients in treatment group were given QHHX granules,and patients in control group were given the same amount of placebo for 12 weeks.During treatment,patients were followed up once a week,and all patients were given diet and exercise guidance.To compare the clinical effect of improving uric acid level and difference of serum IL-6 and TNF-α、IFN-γ、IL-1β between two groups after treatment.Meanwhile,the fecal samples of all patients were taken to determine the diversity and abundance of intestinal flora in all patients.Results:After 12 weeks of treatment,diastolic blood pressure of the patients in treatment group decreased with significant difference compared with that in control group (P<0.05);levels of total cholesterol and low-density lipoprotein in treatment group decreased significantly compared with those in control group (P<0.05),and significant difference was also observed compared with that before treatment (all P<0.01);after 12 weeks of therapy,uric acid level of patients in treatment group decreased significantly compared with patients before treatment (P<0.05),and a significant difference was also observed about uric acid between the two groups after treatment (P<0.05);also differences appeared in serum inflammatory factor IFN-γ and IL-1β between the two groups after treatment(P<0.05),but no significant was found about difference in bacterial diversity before and after therapy in treatment group (P>0.05),but differences in the abundance of bacteroidate,actinobacteriota,acidobacteriota,chloroflexi,nitrospirota,nethyllomirabilota and GAL15 were found in phylum level before and after treatment;however,only the abundance of chloroflexi and gemmatimonadota had difference in the control group;in the genus level,there were differences in the abundance of bacteroides,blautia,bifidobacterium,intestinibacter,sphingomonas and gaiella in treatment group before and after treatment.In the control group,only significant difference in abundance of bacillus and sphingomonas appeared before and after treatment (P<0.05).Conclusion:QHHX formula can improve the uric acid level of patients with internal damp-heat syndrome,reduce the total cholesterol and low-density lipoprotein levels and improve the diastolic pressure of patients with hyperuricemia.It may play a metabolic regulatory role by reducing the expression of proinflammatory factors IFN-γ and IL-1β,increasing the abundance of dominant bacteria such as blautia and bifidobacterium and reducing the abundance of bacteria such as bacteroides.

参考文献/References:

[1]渠井泉,祝洁,李青,等.上海远郊某镇老年人群高尿酸症患病率及影响因素调查研究[J].陕西医学杂志,2020,49(3):375-377.
[2]吕雪霞,胡吉东.高尿酸血症患病率调查及临床影响分析[J].临床检验杂志(电子版),2020,9(1):34-35.
[3]李三三,周钰博,吕珍,等.高尿酸与肥胖的交互作用对非酒精性脂肪肝病患病率的影响[J].广州医药,2024,55(8):843-851.
[4]丁平,姬宏利.早发冠心病合并高尿酸血症病人尿酸水平与冠状动脉Gensini积分的相关性分析[J].中西医结合心脑血管杂志,2021,19(3):458-460.
[5]屈文涛,康亚宁,许磊,等.二维斑点追踪技术评价高尿酸血症患者左房功能与心外膜脂肪厚度临床研究[J].陕西医学杂志,2020,49(4):474-505.
[6]陈志亮,黄霞,顾宁.名中医顾宁创制化湿降浊方辨治高尿酸血症经验[J].陕西中医,2023,44(11):1617-1619.
[7]王贤方,刘志东,张园,等.南方汉族人群ABCG2 rs2231142和SLC2A9 rs3733591单核苷酸多态性与高尿酸血症及心血管危险因素的相关性[J].实用医学杂志,2023,39(7):875-880.
[8]许佳佳,张海波.体检人群高尿酸血症中医体质分布及影响因素分析[J].光明中医,2024,39(22):4472-4476.
[9]中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.
[10]RUSTON T J,TIAN D H,BRRON A,et al.Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products:A systematic review and metaanalysis[J].Eur J Trauma Emerg Surg,2024,50:1419-1429.
[11]GAN T M,Ye Y Y,MO G L,et al.Progress of uric acid in cardiovascular disease[J].Cardiovasc Endocrinol Metab,2024,13:1-7.
[12]中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志(中英文),2024,32(7):603-700.
[13]孙黎明,夏晓露,马红萍.高尿酸血症与高血压及心血管疾病关系研究进展[J].陕西医学杂志,2024,53(2):286-288.
[14]周晰溪,裴琼华,李勇,等.高尿酸血症与部分中医偏颇体质的研究进展[J].中国疗养医学,2024,33(7):77-81.
[15]郑美鸿,张斌,李东彩,等.中医体质与血脂、尿酸、体重指数等的相关性研究[J].中华全科医学,2023,21(9):1581-1584.
[16]刘庄约,陈晓雯.老年高尿酸血症中医体质及相关因素分析[J].光明中医,2021,36(8):1249-1251.
[17]赖瑜,吴伟璇,吴诗欣,等.高尿酸血症合并超重/肥胖的中医体质分布及危险因素 Logistic 回归分析[J].广州中医药大学学报,2023,40(2):278-284.
[18]徐朝辉,朱刚,刘传森,等.基于数据挖掘对中医药治疗无症状高尿酸血症的组方用药规律分析[J].中药药理与临床,2021,37(4):204-208.
[19]李然,李显筑.从“湿、热、浊、瘀、虚”论治高尿酸血症临证经验[J].中医学,2024,13(4):642-647.
[20]李宁,马艺鑫,贾连群,等.从肠道微生态探讨湿热体质与高尿酸血症的关系[J].时珍国医国药,2022,33(2):429-431.
[21]HU H,SHAO W,LIU Q,et al.Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion[J].Nat Commun,2022,13:252.
[22]钟方红,皮特俊章,钟琴,等.中药对高尿酸血症患者肠道菌群影响的研究进展[J].陕西中医,2021,42(2):265-268.
[23]闰敏,牛瑞兵,段宝生.肠道菌群在治疗高尿酸血症中的研究进展[J].中国医药导报,2024,21(12):193-195.
[24]杨莹,韩宇,黄锦坚,等.肠道菌群代谢物参与高尿酸血症的病理机制[J].临床与病理杂志,2023,43(9):1631-1641.
[25]施丽娜,单红梅,姚志华.泄浊化瘀颗粒配合双歧杆菌四联活菌片治疗高尿酸血症的临床效果[J].中国医药导报,2024,21(10):98-102.

相似文献/References:

[1]钟方红,皮特俊章,钟 琴,等.中药对高尿酸血症患者肠道菌群影响的研究进展[J].陕西中医,2021,(2):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]
 ZHONG Fanghong,PI Tejunzhang,ZHONG Qin,et al.Research progress of the effect of traditional Chinese medicine on intestinal flora of patients with hyperuricemia[J].,2021,(10):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]
[2]陈志亮,黄 霞,顾 宁.名中医顾宁创制化湿降浊方辨治高尿酸血症经验[J].陕西中医,2023,(11):1617.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.030]
[3]徐芳,陈嫚嫚,韩蕊.加减健脾补肾泄浊汤联合中药足浴治疗高尿酸血症临床疗效及对患者糖脂代谢的影响[J].陕西中医,2025,46(9):1205.[doi:DOI:10.3969/j.issn.1000-7369.2025.09.010]
 XU Fang,CHEN Manman,HAN Rui.Clinical efficacy of modified Jianpi Bushen Xiezhuo decoction combined with traditional Chinese medicine foot bath in the treatment of hyperuricemia and the impact on glucose and lipid metabolism[J].,2025,46(10):1205.[doi:DOI:10.3969/j.issn.1000-7369.2025.09.010]
[4]王宏静,韩蕊,甄维帅,等.中医综合疗法治疗痰湿质高尿酸血症的效果及对患者血清尿酸、血脂水平的影响[J].陕西中医,2025,46(12):1650.[doi:DOI:10.3969/j.issn.1000-7369.2025.12.013]
 WANG Hongjing,HAN Rui,ZHEN Weishuai,et al.The impact of comprehensive traditional chinese medicine therapy on serum ua and LDL-C levels in patients with phlegm-dampness constitution hyperuricemia[J].,2025,46(10):1650.[doi:DOI:10.3969/j.issn.1000-7369.2025.12.013]

备注/Memo

备注/Memo:
国家自然科学基金资助项目(81874377,8210649);陕西省中医体质与疾病防治研究重点实验室开放课题(KF202310);上海交通大学医学院附属第六人民医院院级课题(YNLC201827)
更新日期/Last Update: 2025-10-10